Original Source(s)
Related Content
Oral Shigella Vaccine Hits 89% Efficacy in Challenge Trial
An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.
by Teraya Smith
July 23, 2026
-
3 min
Are GLP-1s Linked to Optic Neuropathy?
A nationwide Swedish cohort found a higher relative risk of anterior ischemic optic neuropathy among GLP-1 receptor agonist users, but the overall risks were low.
July 14, 2026
-
3 min
Side Effects: Bro Science, Actually
Creatine's ATP-buffering trick isn't just for biceps. In mice, it juices up dendritic cells' energy supply, sharpening T-cell priming and shrinking tumors on daily injections. Human DCs got the memo too, at least in a dish. Early days, but a fun plot twist for gym-bag chemistry.
by Kerri Miller
July 8, 2026
-
6 min